Detalhe da pesquisa
1.
Trial of Deferiprone in Parkinson's Disease.
N Engl J Med
; 387(22): 2045-2055, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449420
2.
α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay.
Ann Neurol
; 95(6): 1173-1177, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546204
3.
Foundations of circadian medicine.
PLoS Biol
; 20(3): e3001567, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35324893
4.
Reduced overnight memory consolidation and associated alterations in sleep spindles and slow oscillations in early Alzheimer's disease.
Neurobiol Dis
; 190: 106378, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38103701
5.
Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients.
Mol Genet Metab
; 142(1): 108464, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537426
6.
Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.
Mov Disord
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651526
7.
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
Mov Disord
; 39(3): 462-471, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243775
8.
Large-Scale Screening: Phenotypic and Mutational Spectrum in Isolated and Combined Dystonia Genes.
Mov Disord
; 39(3): 526-538, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214203
9.
[Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics]. / Demenz mit Lewy-Körpern: alte und neue Erkenntnisse Teil 1: Klinik und Diagnostik.
Nervenarzt
; 95(4): 353-361, 2024 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-38092983
10.
[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment]. / Demenz mit Lewy-Körpern: alte und neue Erkenntnisse Teil 2: Behandlung.
Nervenarzt
; 95(4): 362-367, 2024 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-38095659
11.
Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicity.
J Neurosci Res
; 101(2): 263-277, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353842
12.
Dermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early α-Synucleinopathy.
Mov Disord
; 38(6): 1077-1082, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750755
13.
Characteristics of behavioural addiction in Parkinson's disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case-control study.
J Neural Transm (Vienna)
; 130(2): 125-133, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36662280
14.
Detection of neuron-derived pathological α-synuclein in blood.
Brain
; 145(9): 3058-3071, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35722765
15.
Candidate variants in TUB are associated with familial tremor.
PLoS Genet
; 16(9): e1009010, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956375
16.
[Parkinson's and Alzheimer's disease as system-wide neurodegenerative disorders]. / Parkinson- und Alzheimer-Erkrankung als Systemerkrankungen.
Nervenarzt
; 94(10): 875-884, 2023 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-37672086
17.
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
Ann Neurol
; 90(3): E1-E12, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021620
18.
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease.
Ann Neurol
; 90(1): 76-88, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33938021
19.
European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.
Mov Disord
; 37(7): 1360-1374, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791767
20.
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.
Mov Disord
; 37(6): 1131-1148, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445419